Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis
International Journal of Molecular Sciences · 23.08.2024 · 25 (17) · 9149
DOI: 10.3390/ijms25179149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.08.2024. Verfasst von Anupama Vadhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin 632007, Taiwan. Hauptthemen laut MEDLINE: Exosomes, Osteoarthritis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Geriatrics and Welfare Research at National Health Research Institutes.
Abstract (Originalsprache)
Osteoarthritis (OA) is a leading cause of pain and disability worldwide in elderly people. There is a critical need to develop novel therapeutic strategies that can effectively manage pain and disability to improve the quality of life for older people. Mesenchymal stem cells (MSCs) have emerged as a promising cell-based therapy for age-related disorders due to their multilineage differentiation and strong paracrine effects. Notably, MSC-derived exosomes (MSC-Exos) have gained significant attention because they can recapitulate MSCs into therapeutic benefits without causing any associated risks compared with direct cell transplantation. These exosomes help in the transport of bioactive molecules such as proteins, lipids, and nucleic acids, which can influence various cellular processes related to tissue repair, regeneration, and immune regulation. In this review, we have provided an overview of MSC-Exos as a considerable treatment option for osteoarthritis. This review will go over the underlying mechanisms by which MSC-Exos may alleviate the pathological hallmarks of OA, such as cartilage degradation, synovial inflammation, and subchondral bone changes. Furthermore, we have summarized the current preclinical evidence and highlighted promising results from in vitro and in vivo studies, as well as progress in clinical trials using MSC-Exos to treat OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin 632007, Taiwan.
- Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan.
- Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
ORCID-Profile: Anupama Vadhan, Tanvi Gupta, Wen-Li Hsu
Förderung
- National Center for Geriatrics and Welfare Research at National Health Research Institutes
Zitieren
APA
Vadhan, A., Gupta, T., & Hsu, W. L. (2024). Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis. International Journal of Molecular Sciences, 25(17), 9149. https://doi.org/10.3390/ijms25179149
Vancouver
Vadhan A, Gupta T, Hsu WL. Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis. International Journal of Molecular Sciences. 2024;25(17):9149. doi:10.3390/ijms25179149
BibTeX
@article{Vadhan2024,
author = {Vadhan, Anupama and Gupta, Tanvi and Hsu, Wen-Li},
title = {Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9149},
doi = {10.3390/ijms25179149}
}
EUVIMED